Zurich Insurance Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-72,001
Closed -$12.1M 508
2019
Q3
$12.1M Buy
72,001
+2,357
+3% +$384K 0.23% 111
2019
Q2
$11.7M Sell
69,644
-39,014
-36% -$5.4M 0.23% 123
2019
Q1
$15.9M Buy
108,658
+57,941
+114% +$8.4M 0.34% 83
2018
Q4
$6.78M Sell
50,717
-23,667
-32% -$3.88M 0.16% 171
2018
Q3
$14.2M Buy
74,384
+20,003
+37% +$3.67M 0.3% 95
2018
Q2
$9.07M Sell
54,381
-417
-0.8% -$66.9K 0.2% 141
2018
Q1
$9.22M Buy
54,798
+3,696
+7% +$620K 0.21% 125
2017
Q4
$8.36M Buy
51,102
+6,259
+14% +$1.12M 0.2% 119
2017
Q3
$9.19M Sell
44,843
-4,990
-10% -$1.16M 0.25% 92
2017
Q2
$12.1M Buy
+49,833
New +$11.7M 0.34% 63

Other funds holding AGN

Zurich Insurance Group's AGN Position: Q4 2019 in Review

Zurich Insurance Group sold out of Allergan plc (AGN) in Q4 2019, closing a stake of 72,001 shares — an estimated $12.1M sold.

Zurich Insurance Group first reported a position in AGN in Q2 2017 and held it in 10 quarters. The position peaked at $15.9M in Q1 2019. 957 funds tracked by Wall St. Rank hold AGN as of Q4 2019.

  • Zurich Insurance Group reported no remaining Allergan plc position as of Q4 2019 after selling out during the quarter.
  • Zurich Insurance Group sold 72,001 Allergan plc shares in Q4 2019, an estimated $12.1M.
  • Zurich Insurance Group first reported a position in Allergan plc in Q2 2017 and held it in 10 quarters.
  • Zurich Insurance Group's Allergan plc position peaked at $15.9M in Q1 2019.
  • 957 funds tracked by Wall St. Rank held Allergan plc as of Q4 2019.

Based on Zurich Insurance Group's 13F filing for Q4 2019, filed 14 Feb 2020.